<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03595306</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00087214</org_study_id>
    <nct_id>NCT03595306</nct_id>
  </id_info>
  <brief_title>Human Gut Microbiota and Prebiotic Response</brief_title>
  <official_title>Human Gut Microbiota and Prebiotic Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to examine the shift in gut microbiota and their metabolism after
      consumption of a dietary supplement (prebiotic) by healthy participants. The investigators
      will provide participants with a panel of over the counter prebiotics and monitor their gut
      microbiome response in stool. All prebiotics will be commercially available, over-the-counter
      food, food additives, or dietary supplements, without any known market-use adverse effects
      beyond minimal discomfort.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">May 19, 2019</completion_date>
  <primary_completion_date type="Actual">May 19, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in levels of SCFAs in stool samples</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in levels of cytokines in stool samples</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Healthy Gut Microbiota</condition>
  <arm_group>
    <arm_group_label>Prebiotic A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Prebiotic B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Prebiotic C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Prebiotic A - inulin</intervention_name>
    <description>Pre-weighed packages will be given twice daily for 5 days.</description>
    <arm_group_label>Prebiotic A</arm_group_label>
    <arm_group_label>Prebiotic B</arm_group_label>
    <arm_group_label>Prebiotic C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Prebiotic B - galactooligosaccharides(GOS)</intervention_name>
    <description>Pre-weighed packages will be given twice daily for 5 days.</description>
    <arm_group_label>Prebiotic A</arm_group_label>
    <arm_group_label>Prebiotic B</arm_group_label>
    <arm_group_label>Prebiotic C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Prebiotic C - wheat dextrin</intervention_name>
    <description>Pre-weighed packages will be given twice daily for 5 days.</description>
    <arm_group_label>Prebiotic A</arm_group_label>
    <arm_group_label>Prebiotic B</arm_group_label>
    <arm_group_label>Prebiotic C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provide Stool Samples at no risk to yourself

        Exclusion Criteria:

          -  No oral antibiotic treatments within previous 1 month

          -  No known allergy to milk products or lactose intolerance

          -  no known allergy to wheat or gluten intolerance

          -  no history of irritable bowel syndrome

          -  no history of inflammatory bowel disease

          -  no history of type-2 diabetes

          -  no history of chronic kidney disease or reduced kidney function

          -  no current intestinal obstructions

          -  no current untreated colorectal cancer

          -  not currently pregnant or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence David</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>July 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2018</study_first_posted>
  <last_update_submitted>May 31, 2019</last_update_submitted>
  <last_update_submitted_qc>May 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

